Skip to main content
Caplight Logo









Altrovia

Altrovia

Private
New York City, New YorkHealthcare & Life Scienceshttps://altrovia.ai/

Last Round

Accelerator

Jun 3, 2026

Total Funding Raised

$45,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Altrovia is a digital health company that provides an AI-enabled protocol intelligence platform for clinical development teams to streamline and optimize clinical trial design.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, NLP & Conversational AI, Compliance & Risk, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial designprotocol intelligenceeClinical softwareclinical trial softwarecontract research organizationCROclinical trial managementregulatory complianceclinical document generationAI-assisted authoringamendment predictionclinical trial analyticspharma techbiotech softwarevertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Altrovia Comparables

Compare Altrovia with similar companies based on industry and business-model similarity.

Altrovia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Faro Health
78%
ZS
76%
Dassault Systèmes
74%

Altrovia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 3, 2026
GrantMar 11, 2026
AcceleratorJan 20, 2026

Altrovia Investors

Notable investors and investment history

Altrovia investors
InvestorRounds
NYU Entrepreneurial InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $15K raised from NYU Entrepreneurial Institute.

  • Mar 11, 2026

    $29K grant round completed.

Altrovia Filings

Explore SEC and related filing metadata, where available.

Altrovia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Altrovia's valuation, stock price, and market status.

Is Altrovia a public or private company?

Altrovia is a private company.

What is the current stock price of Altrovia?

Altrovia is a private company with no public stock price. No recent secondary market data is available.

How much is Altrovia worth (valuation)?

Valuation information for Altrovia is not publicly available.

Can I buy Altrovia stock?

Altrovia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Altrovia's last funding round?

Funding round information for Altrovia is not publicly available.

Who are the main investors in Altrovia?

Investor information for Altrovia is not publicly disclosed.

Will Altrovia IPO soon?

No public IPO plans have been announced for Altrovia.

How can I track Altrovia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altrovia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range1
Year Founded2025
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?